Abivax SA (ABVX) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.43x
Abivax SA (ABVX) has a Cash Flow-to-Debt Ratio of -0.43x as of March 2026, meaning its operating cash flow of €-50.52 Million could theoretically repay 0% of its total liabilities (€117.55 Million) in one year. See Abivax SA leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.43x
Operating CF / Total Liabilities
Operating Cash Flow
€-50.52 Million
EUR
Total Liabilities
€117.55 Million
EUR
Data as of
Mar 2026
Most recent filing
Abivax SA Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Abivax SA across 13 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Abivax SA.
Annual Cash Flow-to-Debt Ratio for Abivax SA (2013–2025)
Year-by-year debt coverage analysis for Abivax SA.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.26x | €-162.09 Million | €129.14 Million | ▼ -34.1% |
| 2024 | -0.94x | €-154.07 Million | €164.64 Million | ▼ -26.3% |
| 2023 | -0.74x | €-97.13 Million | €131.05 Million | ▲ +19.2% |
| 2022 | -0.92x | €-65.58 Million | €71.47 Million | ▼ -64.0% |
| 2021 | -0.56x | €-45.66 Million | €81.59 Million | ▼ -25.0% |
| 2020 | -0.45x | €-29.82 Million | €66.62 Million | ▲ +34.9% |
| 2019 | -0.69x | €-27.47 Million | €39.95 Million | ▲ +8.7% |
| 2018 | -0.75x | €-14.60 Million | €19.39 Million | ▲ +49.8% |
| 2017 | -1.50x | €-8.45 Million | €5.63 Million | ▲ +62.7% |
| 2016 | -4.02x | €-15.61 Million | €3.88 Million | ▼ -22.3% |
| 2015 | -3.29x | €-14.90 Million | €4.53 Million | ▼ -301.3% |
| 2014 | -0.82x | €-3.31 Million | €4.03 Million | ▼ -10.2% |
| 2013 | -0.74x | €-3.31 Million | €4.44 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.